WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 3 fonti

AstraZeneca chief executive hails ‘vital importance of US’ as Trump tariffs loom

Pascal Soriot refuses to be drawn, however, on reports AZ could move its main stock market listing across the Atlantic

Raccontata dacnbc.comtelegraph.co.uktheguardian.com

Confronto fonti

3 prospettive sulla stessa storia
AI · summaries
theguardian.comStai leggendo11 mesi fa

AstraZeneca chief executive hails ‘vital importance of US’ as Trump tariffs loom

Pascal Soriot refuses to be drawn, however, on reports AZ could move its main stock market listing across the Atlantic

originale
telegraph.co.uk11 mesi fa

UK-listed AstraZeneca: ‘We are a very American company’

Pascal Soriot declares his ‘love’ for US amid fears his pharma giant could quit the FTSE

Leggi questa versione → originale

Timeline cronologica

  1. martedì 29 luglio 2025·cnbc.com

    AstraZeneca CEO doubles down on U.S. amid rumors of listing shift

    AstraZeneca CEO Pascal Soriot said the U.K.-listed company had many reasons to be in the U.S., adding that it was "rapidly transferring manufacturing" across the Atlantic.

  2. martedì 29 luglio 2025·telegraph.co.uk

    UK-listed AstraZeneca: ‘We are a very American company’

    Pascal Soriot declares his ‘love’ for US amid fears his pharma giant could quit the FTSE

cnbc.com11 mesi fa

AstraZeneca CEO doubles down on U.S. amid rumors of listing shift

AstraZeneca CEO Pascal Soriot said the U.K.-listed company had many reasons to be in the U.S., adding that it was "rapidly transferring manufacturing" across the Atlantic.

Leggi questa versione → originale
  • martedì 29 luglio 2025·theguardian.com

    AstraZeneca chief executive hails ‘vital importance of US’ as Trump tariffs loom

    Pascal Soriot refuses to be drawn, however, on reports AZ could move its main stock market listing across the Atlantic